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A best evidence topic in surgery was written according to a structured protocol. The question addressed
was: in patients with symptomatic gallstones and concomitant common bile duct (CBD) stones, is a
single-stage surgical strategy (laparoscopic cholecystectomy (LC) with common bile duct exploration)
preferable, or a two-stage procedure involving LC with pre or post-operative endoscopic retrograde
cholangiography (ERCP)? Two hundred and six papers were found using the reported search, of which
four presented the best evidence to answer the clinical question. The authors, journal, date and country
of publication, patient group, study type, relevant outcomes and results of these papers are tabulated. A
recent large meta-analysis concluded no signiﬁcant difference in the clinical effectiveness or complica-
tion rate of either strategy. Three recent smaller studies concurred with this conclusion; however each
noted improved cost-effectiveness of the single-stage approach advocating its use as the superior
strategy when local resources and expertise are available.
We conclude that for patients with symptomatic gallstones and concomitant choledocholithiasis, a
single-stage surgical procedure is equivalent to two-stage LC and ERCP in terms of clinical outcomes, is
associated with a shorter overall hospital stay and may be more cost-effective. On this basis a single-
stage procedure is recommended for management of symptomatic gallstones and choledocholithiasis
where local resources and expertise permit.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
In most UK hospitals there are two broad options for manage-
ment of patients found to have choledocholithiasis during in-
vestigations for symptomatic gallstones: a solely surgical strategy
which comprises laparoscopic cholecystectomy (LC) and clearance
of CBD stones in one sitting, or a two-stage approach consisting of
LC and pre- or post-operative ERCP. In order to investigate which is
preferable, a Best Evidence Topic was constructed according to a
structured protocol as described in a previous publication by the IJS
[1]. This is a validated method of appraising current evidence to
answer relevant clinical questions.St George's Healthcare NHS
enny), okhan342@gmail.com
by Elsevier Ltd. All rights reserved2. Clinical scenario
You are at a management meeting discussing ways to save
money within the department. It is noted that patients requiring
cholecystectomy as well as clearance of CBD stones usually undergo
two procedures (LC followed or preceded by ERCP), and it is pro-
posed that suitable patients could instead be treated at a single
sitting. You are competent to perform laparoscopic exploration of
common bile duct (LCBDE), but are uncertain if this leads to
improved outcomes or cost-effectiveness. You resolve to check the
literature to determine the relative efﬁcacy and cost-effectiveness
of the single-stage surgical and two-stage strategies.3. Three-part question
In patients found to have CBD stones in addition to gallstones, is
a single-stage superior to two-stage strategy for stone clearance?.
Table 1
Best evidence papers.
Author, date and country,
study type and
level of evidence
Subject group Outcomes Key results Comments
Lu et al. (2012)
World Journal
Gastroenterology
(China)
Meta-analysis
Level Ia
Seven eligible RCT's comprising
of 787 patients.
5 trials (n ¼ 621) compared
preoperative ERCP þ LC with
LC þ LCBDE. 2 trials (n ¼ 166)
compared LC þ LCBDE with
LC þ post-operative ERCP.
Group 1: Two stage pre/post-
operative ERCP þ LC
Group 2: Single stage
LC þ LCBDE
Successful duct
clearance
Group 1: 78.8%
Group 2:87.2%
p ¼ 0.17
This was a well conducted large study
looking at short term outcomes
between the two groups.
Authors concluded that single stage
management is equivalent to two stage
management, with the decision for
either dependent on local resources and
expertise.
This study is limited in the
heterogeneity that exists between trials
and likely publication bias
Post-operative
morbidity
Group 1: 15.2%
Group 2: 19.0%
p ¼ 0.16
Conversion to other
procedures
Group 1:13.9%
Group 2: 12.0%
p ¼ 0.39
Total operative
time
No statistically signiﬁcant
difference between the two
groups (MD ¼ 12.14, 95%
CI: 1.83 to 26.10, p ¼ 0.09)
Length of hospital
stay
No statistically signiﬁcant
difference between the two
groups (MD ¼ 0.99, 95%
CI: 1.59 to 3.57, p ¼ 0.45)
Bansal et al. (2014)
Surgical Endoscopy, (USA)
[5]
Prospective randomized
control trial
Level 1b
From February 2009 to October
2012, 168 patients were
randomized: 84 to the single
stage procedure (group 1) and
84 to the two stage procedure
(group 2). Both groups were
matched with regard to
demographic and clinical
parameters.
Successful CBD
exploration
Group 1: 91.7%
Group 2: 88.1%
p ¼ 0.22
This was a well conducted large study
looking at short term outcomes
between the two groups.
The two stage procedure was
signiﬁcantlymore expensive (p < 0.001)
but there was no signiﬁcant difference
between the two groups in terms of
wound infection rate or major
complications.
Limitations exist in that LCBDE was
performed almost entirely via
choledochotomy and not transcystically
leading to increased operative time and
bile leak. The cost-effectiveness ratio
used does not take into account quality
of life and the results of such a
composite variable may not be
generalisable, as they depend on
relative costs of resources and
complication rates which vary between
centres.
Successful CBD
clearance
Group 1: 88.1%
Group 2: 79.8%
p ¼ 0.069
Mean operative
time (min)
Group 1: 135.7 ± 36.6
Group 2: 72.4 ± 27.6
p < 0.001
Group 2 signiﬁcantly shorter
operative time
Overall hospital
stay (days)
Group 1: 4.6 ± 2.4
Group 2: 5.3 ± 6.2
p ¼ 0.03
Group 1 signiﬁcantly shorter
hospital stay
Average cost of
procedure per
patient (US $)
Group 1: $394.1± $133.1
Group 2: $506.5± $235.3
p < 0.001
Group 1 signiﬁcantly lower cost
of procedure
Incremental cost-
effectiveness ratio
(US $)
$-1182.7 e This indicates the
single stage laparoscopic CBD
exploration more effective and
less costly than the two stage
procedure.
Lu et al. (2013)
American
Surgeon (USA)
Retrospective case
control study
Level IIb
One-stage versus two stage
management for concomitant
gallbladder stones and common
bile duct stones in patients with
obstructive jaundice.
One-stage management
(n ¼ 88) or two stage
management (n ¼ 122) was
used for 210 eligible patients
between January 2009 and
March 2011.
Stone clearance
from the common
bile duct (CBD)
One-stage: 93.2%
Two stage: 95.1%
p ¼ 0.28
This was a well conducted large study
looking at short term outcomes
between the two groups.
One-stage management was more cost-
effective and decreased the number of
procedures. In addition, post-operative
hospital stay and operative time were
shorter for patients who received one-
stage management.
This paper is limited by surgeon bias
within the same centre as to choice of
management.
Post-operative
morbidity
One stage: 10.2%
Two stage: 15.6%
p ¼ 0.12
Mortality One stage: 0.0%
Two stage: 0.8%
p ¼ 0.16
Conversion to open One stage: 6.8%
Two stage: 9.8%
p ¼ 0.21
Operative time
(min)
One stage: 98.7 ± 9.7
Two stage: 126.9 ± 19.5
p < 0.001
One stage signiﬁcantly shorter
Length of stay
(days)
One stage: 5.1 ± 2.5
Two stage: 7.9 ± 3.9
p < 0.001
One stage signiﬁcant shorter
Cost-effectiveness
1 Surgical charges
2 Total charges
One stage:
1 $921 ± $127.1
2 $1310.5 ± $199.4
Two stage:
1 $3473.1 ± $1116.3
2 $4157.8 ± $1106.0
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Table 1 (continued )
Author, date and country,
study type and
level of evidence
Subject group Outcomes Key results Comments
p < 0.001 (for both 1 & 2)
One stage signiﬁcantly more
cost-effective
Topal et al. (2010) Surgical
endoscopy (Netherlands)
Retrospective case
control study
Level IIb
Between October 2005 and
September 2006 53 patients
presenting with symptoms of
gallstone disease were
managed for CBD stones with
either a one or two stage
procedure
38 patients were identiﬁed as
eligible for cost analysis
Group 1 (19 patients): One
stage procedure
Group 2 (19 patients): Two
stage procedure
Hospitalisation cost
(V)
Group 1: 701 (0e2599)
Group 2: 2190 (723e4471)
p < 0.0001
This was a well conducted small study
looking at hospitalization costs
categories between the two groups.
This paper concludes that the
management of concomitant CBD and
gallstone disease should be single stage
providing local expertise is available,
based on signiﬁcantly reduced costs
compared to the two stage procedure.
This paper is limited by its small sample
size (19 patients in each) and by the fact
that cost data determined is difﬁcult to
compare internationally with respect to
large diversities within healthcare
systems, socio-economic aspects and
insurance policies.
Operation costs (V) Group 1: 1278 (616e1884)
Group 2: 1232 (720e2356)
p ¼ 0.280
Medical staff costs
(V)
Group 1: 638 (313e994)
Group 2: 720 (443e1133)
p ¼ 0.062
Paramedical staff
costs (V)
Group 1: 1035 (299e1875)
Group 2: 1860 (923e2973)
p ¼ 0.0002
Pharmacy/
consumables cost
(V)
Group 1: 645 (185e1013)
Group 2: 1476 (298e2193)
p < 0.0001
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Medline 1990 toMarch 2014 using the PUBMED interface for the
term: (‘Common bile duct’ [MeSH] OR CBD) AND (stone OR ‘calculi’
[MeSH]) AND (laparoscopic cholecystectomy OR ‘laparoscopy’
[MeSH]) AND (‘cholangiopancreatography’ [MeSH] OR ‘endoscopic
retrograde’ [MeSH] OR ERCP). The search was ﬁltered for English
articles to includemeta-analyses, randomised and non-randomised
control trials, systematic reviews and comparative studies. The
reference lists for articles identiﬁed as relevant were also reviewed.
The search was valid as of 8th of April 2014.
5. Search outcome
Two hundred and six papers were found using the reported
search. One hundred and twenty-ﬁve papers were irrelevant; 26
papers were excluded because they were not in English, 28 papers
were technical reports describing surgical techniques, nine papers
were case reports and six papers investigated the diagnosis of CBD
stones. Of the remaining 12 papers, seven relevant randomised
control trials were covered by a single meta-analysis, and onewas a
systematic review superseded by the meta-analysis previously
identiﬁed. Three further papers, one randomised control trial and
two case control studies were identiﬁed as representing the best
evidence to answer this clinical question (Table 1) [2e5].
6. Results
Please refer to Table 1: Best evidence topics.
7. Discussion
The prevalence of patients awaiting laparoscopic cholecystec-
tomy for symptomatic gallstone diseasewho also have concomitant
CBD stones is 3e10% [2]. There are three options for the manage-
ment of such CBD stones; (i) conservative management (ii) surgical
exploration of the CBD with stone retrieval or (iii) ERCP. Conser-
vative management is reserved for non-obstructing CBD stones,
with one third estimated to pass spontaneously within six weeks of
cholecystectomy [6]. For obstructing CBD stones, intervention is
required. A single-stage surgical strategy with LCBDE and stone
retrieval at the time of LC has the advantage of signiﬁcantly shorter
overall hospital stay [4]. An alternative option is two-stage surgicaland endoscopic management, with LC and ERCP on separate dates
for CBD stone clearance. An advantage of this approach is signiﬁ-
cantly shorter surgical time [3], but patients are exposed to the
risks associated with ERCP such as pancreatitis in up to 5% [7], and
delays between the two-stages of treatment may result in pro-
longed hospital admission [3].
Lu et al. [2] in 2012 performed a meta-analysis to compare
clinical outcomes of one-stage LCBDE at the time of LC versus two-
stage LC preceded or followed by ERCP and clearance of common
bile duct stones. Seven trials with 787 patients were included, with
a total of 387 patients undergoing a single-stage surgical procedure
for stone clearance and 400 patients a two-stage LC with pre- or
post-operative ERCP. Inclusion criteria for all randomised
controlled trials required patients to have symptomatic gallstones
and to be suspicious for, or proven to have, CBD stones based on
clinical presentation (jaundice, cholangitis, pancreatitis), deranged
liver function tests or imaging (ultrasound, MRCP or intraoperative
cholangiography). Outcomes measured were successful duct
clearance, mortality, post-operative patient morbidity, conversion
to other procedure, total operative time and length of hospital stay.
For none of these variables was there a statistically signiﬁcant
difference when comparing a single versus two-stage management
strategy (Table 1).
Lu's meta-analysis is a comprehensive review of the evidence
available at the time of publication; however, as with any meta-
analysis, it is limited by the quality of the seven papers on which
it is based. The majority of these studies are underpowered, with all
but two studies having 50 patients or less in each arm. They are also
likely to be subject to publication bias, with asymmetry shown in
the funnel plot analysis, and there is statistical heterogeneity be-
tween their measurements. The systematic review also only
included trials published in English.
Since Lu's meta-analysis two large studies have taken place
adding 378 patients to the evidence base. In 2014, Bansal et al. [3]
performed a randomised controlled trial to investigate the effect
of single versus two-stage strategies for the treatment of symp-
tomatic gallstones and concomitant CBD stones. One hundred and
sixty eight patients conﬁrmed on imaging to have concomitant CBD
and gallstones were randomised to either single-stage LCBDE and
LC (group 1) or ERCP for endoscopic extraction of the CBD stones
followed by LC (group 2). Success was deﬁned as LC and complete
clearance of CBD by intended method. In addition a number of
secondary outcomes were measured, including cost effectiveness
R. Kenny et al. / International Journal of Surgery 12 (2014) 989e993992which was measured using the incremental cost-effectiveness ra-
tio, calculated as the (average cost of single-stage  average cost of
two-stage) divided by (average effect of single-stage  average
effect of two-stage). The average effect of each groupwas calculated
by dividing the total number of patients with an uneventful post-
operative course by the total number of patients in each group [3].
This study concluded that LCBDE trended to having a higher
overall success rate as compared to the two-stage procedure,
although this was not statistically signiﬁcant (p ¼ 0.069). LCBDE as
a single-stage strategy was shown to result in signiﬁcantly shorter
overall hospital stay (p ¼ 0.03), and was associated with signiﬁ-
cantly reduced cost total cost (p < 0.001) despite signiﬁcantly
increased operating time (p < 0.001). Within the discussion, the
authors explain that the major contributory factors to inﬂuence
cost are operative time, length of hospital stay, number of pro-
cedures and rate of complications. This paper is the ﬁrst to include a
cost-effectiveness analysis as of the single surgical compared to
two-stage strategies for patients' requiring both LC and CBD stone
clearance. The results of such a composite variable may not be
generalisable, as they depend on relative costs of resources and
complication rates which vary between centres. An additional
limitation of this study is that although LCBDE may be performed
via choledochotomy or via a trans-cystic approach, with each
technique carrying separate risk proﬁles, almost all LCBDE in this
study were performed via choledochotomy. The authors suggest
that a higher rate of bile-leak in the single-stage cohort as
compared to the two-stage group may be due to this chol-
edochotomy technique of LCBDE however this cannot be demon-
strated by their data. Tokumura et al. [8] in 2002 found trans-cystic
approach to be associated with reduced morbidity (notable less
frequent bile leakage) and shorter hospital stay compared to
choledochotomy.
Lu et al. [4] in 2013 followed on from their previous meta-
analysis [2] by performing a retrospective study evaluating the
effectiveness and safety of a one-stage (LC plus LCBDE) versus two-
stage (ERCP and LC) strategy for patients with symptomatic gall-
stones and concomitant choledocholithiasis. Two hundred and ten
eligible patients underwent one-stage (n ¼ 88) or two-stage
(n ¼ 122) management strategies. No signiﬁcant difference was
observed for the outcomes of CBD stone clearance, post-operative
morbidity, mortality and conversion to open surgery. A one-stage
strategy was shown to have signiﬁcantly lower surgical ($921 vs
$3473.1) and total cost ($1310.5 vs $4157.8) in comparison to a two-
stage strategy (p < 0.001).
This study was non-randomised and despite being from a single
institution, both cohorts were well matched in terms of pre-clinical
characteristics. Its limitations are inherent to its design; decisions
for treatment strategy were made by ﬁve surgeons operating
within a single centre, according to individual preference and thus
susceptible to bias. Cost-effectiveness was approximated by the
cost of surgical charges and total charges in US dollars, however no
description of how these costs were calculated, or how they
correlate to cost effectiveness is mentioned.
Topal et al., in 2010 [5] looked speciﬁcally at the issue of cost
variance between one and two-stage management of common bile
duct stones. In 335 consecutive patients between October 2005 and
September 2006 presenting with symptoms of gallstone disease, 53
were managed for CBD stones with either a one or two-stage
procedure. Decision for therapeutic intervention was based on lo-
gistic reasons at the time of presentation, with expertise available
in both ERCP and LCBDE throughout. Exclusion criteria consisted
patients transferred from another unit (three), ERCP post laparo-
scopic cholecystectomy (one) and post-operative complications
after either ERCP or LCBDE (three and four respectively). 38 patients
were identiﬁed as eligible for cost analysis: 19 one-stagemanagement and 19 two-stagemanagement patients. Cost analysis
started at the time of admission and ended at the time of discharge.
A cost accounting model was developed based on the concept of
activity-based costing; hospital activities were allocated into ‘cost
centres’ with different cost categories within each activity linked to
the individual patient via the ‘bill of activities’. Cost drivers were
identiﬁed at each cost centre assumed to be most responsible for
costs, with all costs (direct and indirect) linked to the individual
patient according to these drivers. Costs were calculated in euros.
Costs per patient were signiﬁcantly less after a one-stage versus
two-stage procedure (p< 0.0001). Operation costs were found to be
not statistically different (p ¼ 0.28) however hospitalization costs
(p < 0.0001), pharmacy costs (p < 0.0001) and para-medical
personnel costs (p ¼ 0.0002) were all signiﬁcantly reduced for
the one-stage procedure.
This paper concludes that the management of concomitant CBD
and gallstone disease should be single-stage providing local
expertise is available, based on signiﬁcantly reduced costs
compared to the two-stage procedure. This paper is limited by its
small sample size (19 patients in each) and by the fact that cost data
determined is difﬁcult to compare internationally with respect to
large diversities within healthcare systems, socio-economic aspects
and insurance policies.
A meta-analysis performed by Alexakis et al., in 2012 [9]
examining single versus two-stage approaches for the treatment
of choledocholithiasis included trials in which the single-stage
strategy consisted of LC plus intraoperative ERCP. It concluded
that single-stage and two-stage strategies are equivocal in terms of
clinical outcomes but more research is needed into long term
outcomes such as quality of life, and cost effectiveness. Intra-
operative ERCP is a procedure performed very rarely in the UK
largely due to the need for the equipment and expertise of both a
surgeon and gastroenterologist in the same sitting, and for this
reason has not been included in the present analysis.
In conclusion the Lu meta-analysis performed in 2012 [2] in-
dicates that there is no signiﬁcant difference in the clinical out-
comes of a single-stage surgical strategy for the removal of CBD
stones versus a two-stage strategy. This is a conclusion that has
been reinforced by subsequent studies. However, more recent ev-
idence cites additional beneﬁts of a single-stage strategy in terms of
both cost and length of hospital stay [3e5]. There is a need for
further research into the health economics and quality of life var-
iables within this ﬁeld.
8. Clinical bottom line
A single-stage surgical versus two-stage strategy in the treat-
ment of concomitant CBD and gallstone disease has been shown to
be equivalent in terms of clinical complications. The single-stage
approach has been shown to carry greater cost-effectiveness with
reduced length of hospital stay and on this basis should be the
preferred procedure where resources and local expertise are
available.
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